BioCentury
ARTICLE | Clinical News

SciFluor preclinical data

July 29, 2013 7:00 AM UTC

In a mouse model of epilepsy, SF0034 led to a 5-fold increase in potency with reduced corrected QT (QTc) liabilities and a more balanced excretion prole compared to Potiga ezogabine. Data were presen...